| Financial Year |
March 31 2023 |
| Monetary Funds |
112,958,938.68 |
| Held-for-trading Financial Assets |
149,040,000.00 |
| Notes Receivable |
38,105,044.89 |
| Accounts Receivable |
622,854,482.27 |
| Advances to Suppliers |
195,342,467.00 |
| Other Receivables |
1,553,197.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,798,371,747.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,306,054.24 |
| Total Current Assets |
3,069,387,629.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
521,294,643.36 |
| Investment Properties |
85,393,689.27 |
| Fixed Assetes |
1,433,684,409.20 |
| Under-construction Projects |
22,644,072.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
97,380,865.79 |
| R&D expenses |
-- |
| Goodwill |
5,365,400.84 |
| Long-Term Deferred and Prepaid Expenses |
606,051.95 |
| Deferred Income Tax Assets |
55,721,632.26 |
| Other Non-Current Assets |
8,238,458.50 |
| Sub-Total of Non-Current Assets |
2,305,901,338.75 |
| Total Assets |
5,375,288,968.66 |
| Short-Term Loans |
60,061,666.69 |
| Trading Financial liabilities |
-- |
| Notes Payable |
531,158,934.60 |
| Accounts Payable |
205,447,385.41 |
| Accounts Received In Advance |
1,465,738.97 |
| Employee Compensation Payable |
25,564,411.08 |
| Taxes Payable |
6,866,893.41 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
25,803,829.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,519,528.31 |
| Other Current Liabilities |
14,692,357.68 |
| Sub-Total of Current Liabilities |
886,749,138.00 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
150,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
186,144,650.69 |
| Total Liabilities |
1,072,893,788.69 |
| Paid-In Capital(Or Share Stock) |
959,273,120.00 |
| Capital Surplus |
1,676,456,219.02 |
| Surplus Reserve |
234,941,084.49 |
| LESS:Treasury Stock |
12,805,860.00 |
| Undistributed Profits |
1,353,509,932.40 |
| Minority Stockholder's Interest |
19,652,694.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,282,742,485.04 |
| Owner's Equity（Stockholder's Equity） |
4,302,395,179.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,375,288,968.66 |
